Antibody-drug conjugates (ADCs) are transforming oncology treatment for breast cancer patients (and other patients, too! They can be used in different cancer treatment regimens.) ADCs are founded in the concept of a “magic bullet,” which was developed by Paul Ehrlich, the founder of chemotherapy treatment. Paul Ehrlich’s work was done over 100 years ago- he…